PTI-1
Get PTI-1 essential facts below. View Videos or join the PTI-1 discussion. Add PTI-1 to your Like2do.com topic list for future reference or share this resource on social media.
PTI-1
PTI-1
PTI-1 structure.png
Legal status
Legal status
Identifiers
CAS Number
ChemSpider
UNII
Chemical and physical data
FormulaC21H29N3S
Molar mass355.54 g/mol
3D model (JSmol)

PTI-1 is an indole-based synthetic cannabinoid.[1] It is one of few synthetic cannabinoids containing a thiazole group and is closely related to PTI-2. These compounds may be viewed as simplified analogues of indole-3-heterocycle compounds originally developed by Organon and subsequently further researched by Merck.[2][3][4][5]

See also

References

  1. ^ "PTI-1". Cayman Chemical. Retrieved 2015.
  2. ^ Julia Adam-Worrall, et al. (Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor. Patent US 7700634, priority date 5 March 2004
  3. ^ Paul David Ratcliffe, et al. Indole Derivatives. Patent US 7763732, priority date 24 August 2005
  4. ^ Julia Adam, et al. Indole Derivatives. Patent WO 2008/101995, priority date 22 February 2007
  5. ^ Takao Kiyoi, et al. Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists. Bioorganic & Medicinal Chemistry Letters 2011; 21(6):1748-1753. doi: 10.1016/j.bmcl.2011.01.082



  This article uses material from the Wikipedia page available here. It is released under the Creative Commons Attribution-Share-Alike License 3.0.

PTI-1
 



 

Top US Cities

Like2do.com was developed using defaultLogic.com's knowledge management platform. It allows users to manage learning and research. Visit defaultLogic's other partner sites below:
PopFlock.com : Music Genres | Musicians | Musical Instruments | Music Industry